We are live on ! Find out more
CIC

Carnegie Investment Counsel Portfolio holdings

AUM $4.99B
1-Year Est. Return 23.08%
This Fund
S&P 500
This Quarter Est. Return
-15.19%
1 Year Est. Return
+23.08%
3 Year Est. Return
+101.05%
5 Year Est. Return
+118.22%
10 Year Est. Return
+474.28%
AUM
$2.21B
AUM Growth
-$530M
Cap. Flow
-$60M
Cap. Flow %
-2.71%
Top 10 Hldgs %
21.62%
Holding
511
New
25
Increased
176
Reduced
220
Closed
40

Top Buys

Rank Stock Value
1
PGNY icon
Progyny
PGNY
+$11M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$8.87M
3
RTX icon
RTX Corp
RTX
+$8.14M
4
AKAM icon
Akamai
AKAM
+$5.56M
5
AYX
Alteryx Inc
AYX
+$4.81M

Sector Composition

Rank Sector Weight
1 Technology 17.48%
2 Financials 13.91%
3 Industrials 11.76%
4 Healthcare 11.27%
5 Consumer Discretionary 7.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTR icon
451
Nutrien
NTR
$32.1B
$202K 0.01%
2,540
VOE icon
452
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24.4B
$202K 0.01%
1,556
+208
+15% +$29.4K
BSMR icon
453
Invesco BulletShares 2027 Municipal Bond ETF
BSMR
$347M
$201K 0.01%
8,500
MPLX icon
454
MPLX
MPLX
$60.8B
$201K 0.01%
6,911
+474
+7% +$15.2K
TSI
455
TCW Strategic Income Fund
TSI
$214M
$190K 0.01%
39,400
CNX icon
456
CNX Resources
CNX
$5.29B
$177K 0.01%
10,775
VKQ icon
457
Invesco Municipal Trust
VKQ
$545M
$177K 0.01%
17,411
+26
+0.1% +$270
PLTR icon
458
Palantir
PLTR
$411B
$173K 0.01%
19,055
-4,935
-21% -$48.8K
FNB icon
459
FNB Corp
FNB
$6.86B
$168K 0.01%
15,476
IHIT
460
DELISTED
Invesco High Income 2023 Target Term Fund Common Shares of Beneficial Interest, No par value per share
IHIT
$158K 0.01%
18,505
+5
+0% +$43
HYT icon
461
BlackRock Corporate High Yield Fund
HYT
$1.37B
$116K 0.01%
12,153
COMS
462
DELISTED
COMSovereign Holding Corp. Common Stock
COMS
$66K ﹤0.01%
+3,876
New +$132K
PACB icon
463
Pacific Biosciences
PACB
$345M
$63K ﹤0.01%
14,250
-21,500
-60% -$131K
ALAR
464
Alarum Technologies
ALAR
$13.3M
$58K ﹤0.01%
+12,008
New +$70.5K
JQC icon
465
Nuveen Credit Strategies Income Fund
JQC
$717M
$56K ﹤0.01%
10,731
-890
-8% -$5K
WKHS icon
466
Workhorse Group
WKHS
$33.7M
$31K ﹤0.01%
+4
New +$37.7K
ALYA
467
DELISTED
Alithya Group Inc Class A Subordinate Voting Shares
ALYA
$24K ﹤0.01%
10,000
RIDE
468
DELISTED
Lordstown Motors Corp. Class A Common Stock
RIDE
$16K ﹤0.01%
+696
New +$22.4K
NMTR
469
DELISTED
9 Meters Biopharma
NMTR
$3K ﹤0.01%
500
AFL icon
470
Aflac
AFL
$60.5B
-3,309
Closed -$213K
ALL icon
471
Allstate
ALL
$64.7B
-1,465
Closed -$203K
BFAM icon
472
Bright Horizons
BFAM
$3.76B
-1,870
Closed -$248K
CHRW icon
473
C.H. Robinson
CHRW
$17.1B
-2,771
Closed -$298K
CMA
474
DELISTED
Comerica
CMA
-2,400
Closed -$217K
COHR icon
475
Coherent
COHR
$69.6B
-2,851
Closed -$207K

Similar funds

Carnegie Investment Counsel's Q2 2022 Portfolio in Review

As of Q2 2022, Carnegie Investment Counsel held 511 positions worth $2.21B, down 19% from $2.74B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Carnegie Investment Counsel's Q2 2022 filing shows 25 new, 176 increased, 220 reduced and 40 closed positions. Its largest new stake was Progyny: 306,283 shares worth $8.9M. The largest sale was Invesco BulletShares 2022 Corporate Bond ETF, an estimated $11.2M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 19% a quarter earlier, followed by Financials and Industrials.

  • Carnegie Investment Counsel's largest Q2 2022 buy was Progyny: 306,283 shares worth $8.9M.
  • Carnegie Investment Counsel added most to Berkshire Hathaway Class B in Q2 2022, an estimated $4.8M increase.
  • Carnegie Investment Counsel's biggest Q2 2022 reduction was Invesco BulletShares 2022 Corporate Bond ETF, cutting an estimated $11.2M.
  • Carnegie Investment Counsel fully exited QuantumScape Corp in Q2 2022, selling an estimated $5.61M.
  • Carnegie Investment Counsel's ten largest holdings make up 22% of its $2.21B portfolio in Q2 2022.
  • Carnegie Investment Counsel opened 25 new positions and closed 40 in Q2 2022.
  • Carnegie Investment Counsel's portfolio value fell 19% quarter-over-quarter to $2.21B.

Based on Carnegie Investment Counsel's 13F filing for Q2 2022, filed 13 Jul 2022.